Related Experiment Video

Updated: Aug 13, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

PTEN function in normal and neoplastic growth

Lionel M L Chow1, Suzanne J Baker

  • 1Department of Developmental Neurobiology, St Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA.

Cancer Letters
|January 18, 2006
PubMed

Insights

The PTEN tumor suppressor regulates cell growth and survival. Its inactivation, common in cancers like glioblastoma, drives tumorigenesis through tissue-specific mechanisms, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The PTEN tumor suppressor is a key negative regulator of the PI3K/AKT signaling pathway.
  • This pathway controls fundamental cellular processes such as growth, survival, proliferation, and migration.
  • Dysregulation of the PI3K/AKT pathway, particularly PTEN alterations, is implicated in numerous human cancers.

Purpose of the Study:

  • To investigate the role of PTEN in regulating the PI3K/AKT signaling cascade.
  • To understand how PTEN inactivation contributes to tumorigenesis in a tissue-specific manner.
  • To identify mechanisms of PTEN loss that could lead to novel cancer therapies.

Main Methods:

  • Analysis of PTEN alterations in human tumor samples.
  • Utilizing animal models to study PTEN inactivation effects.
  • Investigating downstream signaling pathways affected by PTEN loss.

Main Results:

  • PTEN is the most frequently altered component of the PI3K pathway in human malignancies.
  • PTEN mutations are found in both hereditary and sporadic cancers, notably glioblastoma, prostate, and endometrial cancer.
  • Evidence suggests PTEN inactivation has distinct, tissue-specific consequences.

Conclusions:

  • PTEN plays a critical role in preventing cancer by negatively regulating the PI3K/AKT pathway.
  • Understanding the tissue-specific downstream effectors of PTEN loss is crucial for cancer research.
  • Further elucidation of these mechanisms may pave the way for targeted cancer therapeutics.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...